In Situ ocular Gels:A Overview

Pharmacy

The pharmaceutical scientist faces one of the most intriguing and difficult tasks: ocular medication delivery. Due to rapid precorneal drug loss (through dilution and drainage from the eye), high variability in efficiency, and blurred vision, among other factors, conventional ophthalmic formulations (solutions, suspensions, and ointments) have poor bioavailability. Therefore, it was necessary to develop an advanced drug delivery system. The bioavailability of a given medicine is impacted by both static and dynamic obstacles. Prior to administration in the body, polymeric systems are in solution form to address the disadvantages of conventional drug therapy; however, after administration, these systems go through gelation. In situ gels are liquid preparations that, after being injected into the eye, transition into a viscous gel as a result of the changes in the eye's environment. This innovative drug delivery technology encourages the crucial ease and convenience of administration, delivery of an exact dose, and extension of the drug's residence period in contact with mucosa. The main criteria for an effective control release product centre on improving patient compliance, good stability, and biocompatibility traits, which make the in situ gel dosage forms particularly dependable. This overview will outline the fundamental physiology and anatomy of the human eye, as well as the numerous techniques for creating in-situ gels and the few methods that are employed in their creation. These systems are tested for drug content, clarity, pH, gelling ability, viscosity, change in temperature.in vitro drug release research, texture analysis, sterility testing, isotonicity evaluation, accelerated studies, and irritancy test

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.